Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
GOCO Stock Forecast 2025-2026
$5.60
Current Price
$133.43M
Market Cap
Buy 4
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to GOCO Price Targets
+346.4%
To High Target of $25.00
+275.0%
To Median Target of $21.00
+221.4%
To Low Target of $18.00
GOCO Price Momentum
-4.1%
1 Week Change
-13.7%
1 Month Change
-44.0%
1 Year Change
-58.2%
Year-to-Date Change
-73.3%
From 52W High of $21.00
+4.2%
From 52W Low of $5.37
📊 TOP ANALYST CALLS
Did GOCO Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if GoHealth is one of their latest high-conviction picks.
Latest GOCO Stock Price Targets & Analyst Predictions
Based on our analysis of 10 Wall Street analysts, GOCO has a bullish consensus with a median price target of $21.00 (ranging from $18.00 to $25.00). Currently trading at $5.60, the median forecast implies a 275.0% upside. This outlook is supported by 4 Buy, 1 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Ben Hendrix at RBC Capital, suggesting a 221.4% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
GOCO Analyst Ratings
4
Buy
1
Hold
0
Sell
GOCO Price Target Range
Low
$18.00
Average
$21.00
High
$25.00
Current: $5.60
Latest GOCO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for GOCO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 19, 2025 | RBC Capital | Ben Hendrix | Sector Perform | Reiterates | $18.00 |
| Oct 21, 2024 | RBC Capital | Ben Hendrix | Sector Perform | Reiterates | $13.00 |
| Mar 20, 2024 | RBC Capital | Ben Hendrix | Sector Perform | Maintains | $13.00 |
| Apr 4, 2023 | Credit Suisse | Jonathan Yong | Underperform | Maintains | $8.50 |
| Mar 17, 2023 | RBC Capital | Ben Hendrix | Sector Perform | Maintains | $14.00 |
| Aug 26, 2022 | RBC Capital | Ben Hendrix | Sector Perform | Maintains | $1.00 |
| Aug 16, 2022 | Credit Suisse | Jonathan Yong | Underperform | Maintains | $1.25 |
| Mar 16, 2022 | Morgan Stanley | Lauren Schenk | Equal-Weight | Maintains | $1.00 |
| Mar 16, 2022 | Evercore ISI Group | Elizabeth Anderson | In-Line | Maintains | $1.75 |
| Mar 3, 2022 | RBC Capital | Frank Morgan | Sector Perform | Downgrade | $2.00 |
| Mar 2, 2022 | Truist Securities | Hold | Downgrade | $0.00 | |
| Jan 7, 2022 | Credit Suisse | Jailendra Singh | Underperform | Downgrade | $3.00 |
| Jan 5, 2022 | B of A Securities | Michael Cherny | Underperform | Downgrade | $3.50 |
| Nov 15, 2021 | Credit Suisse | Jailendra Singh | Neutral | Maintains | $6.00 |
| Nov 11, 2021 | Morgan Stanley | Equal-Weight | Maintains | $5.50 | |
| Nov 10, 2021 | Barclays | Steve Valiquette | Equal-Weight | Downgrade | $5.00 |
| Nov 10, 2021 | RBC Capital | Frank Morgan | Outperform | Maintains | $10.00 |
| Nov 9, 2021 | Barclays | Equal-Weight | Downgrade | $0.00 | |
| Aug 13, 2021 | Barclays | Steve Valiquette | Overweight | Maintains | $10.00 |
| Aug 12, 2021 | Evercore ISI Group | In-Line | Downgrade | $0.00 |
GoHealth Inc. (GOCO) Competitors
The following stocks are similar to GoHealth based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
GoHealth Inc. (GOCO) Financial Data
GoHealth Inc. has a market capitalization of $133.43M with a P/E ratio of 0.0x. The company generates $834.27M in trailing twelve-month revenue with a 0.2% profit margin.
Revenue growth is +19.1% quarter-over-quarter, while maintaining an operating margin of +5.0% and return on equity of +1.0%.
Valuation Metrics
Market Cap
$133.43M
Enterprise Value
$771.52M
P/E Ratio
0.0x
PEG Ratio
-1.4x
Price/Sales
0.2x
Growth & Margins
Revenue Growth (YoY)
+19.1%
Gross Margin
+82.2%
Operating Margin
+5.0%
Net Margin
+0.2%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+35.6%
Current Ratio
1.1x
Debt/Equity
116.1x
ROE
+1.0%
ROA
+0.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
GoHealth Inc. (GOCO) Business Model
About GoHealth Inc.
What They Do
Health insurance marketplace connecting consumers with plans.
Business Model
GoHealth operates as a technology-driven marketplace, primarily facilitating connections between consumers and Medicare or individual health insurance products. The company generates revenue by earning commissions from insurance providers when users enroll in plans through its platform.
Additional Information
GoHealth plays a significant role in the healthcare industry by improving access to health services, especially for the aging population. It utilizes advanced data analytics and technology to enhance customer acquisition and retention, making the health insurance selection process more efficient.
Company Information
Sector
Financial Services
Industry
Insurance Brokers
Employees
2,261
CEO
Mr. Vijay Kumar Kotte
Country
United States
IPO Year
2020
Website
www.gohealth.comGoHealth Inc. (GOCO) Latest News & Analysis
Latest News
Quick Summary
Rosen Law Firm is investigating potential securities claims for GoHealth, Inc. (NASDAQ: GOCO) shareholders due to allegations of misleading business information. Affected investors may seek compensation without upfront costs.
Why It Matters
Allegations of misleading information from GoHealth could lead to legal claims, impacting shareholder value and market perception, potentially resulting in compensation for affected investors.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Rosen Law Firm is investigating potential securities claims for GoHealth, Inc. (NASDAQ: GOCO) due to allegations of misleading business information to investors.
Why It Matters
The investigation into GoHealth may signal potential legal troubles and financial risk, impacting stock performance and investor confidence in the company.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Rosen Law Firm is investigating potential securities claims against GoHealth, Inc. (NASDAQ: GOCO) for allegedly providing misleading business information to investors.
Why It Matters
Allegations of misleading information can lead to legal actions and regulatory scrutiny, impacting GoHealth's stock price and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
A news report from New York City dated June 8, 2025, indicates an event or announcement; specific details and implications for investors are not provided.
Why It Matters
The date and location suggest potential market-moving events or announcements in New York, which could impact stocks, investor sentiment, or economic forecasts.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
New York City hosted an event on June 9, 2025, as reported by ACCESS Newswire, though details on the event's significance or impact on markets were not provided.
Why It Matters
The news excerpt lacks critical details about economic indicators, corporate performance, or market trends, making it irrelevant for investment decisions.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Bragar Eagel & Squire is investigating GoHealth, Inc. and Abacus Global Management for potential federal securities law violations and unlawful business practices.
Why It Matters
Investigations into GoHealth and Abacus Global Management for potential securities law violations may impact their stock prices and investor sentiment, leading to increased volatility and risk.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About GOCO Stock
What is GoHealth Inc.'s (GOCO) stock forecast for 2025?
Based on our analysis of 10 Wall Street analysts, GoHealth Inc. (GOCO) has a median price target of $21.00. The highest price target is $25.00 and the lowest is $18.00.
Is GOCO stock a good investment in 2025?
According to current analyst ratings, GOCO has 4 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $5.60. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for GOCO stock?
Wall Street analysts predict GOCO stock could reach $21.00 in the next 12 months. This represents a 275.0% increase from the current price of $5.60. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is GoHealth Inc.'s business model?
GoHealth operates as a technology-driven marketplace, primarily facilitating connections between consumers and Medicare or individual health insurance products. The company generates revenue by earning commissions from insurance providers when users enroll in plans through its platform.
What is the highest forecasted price for GOCO GoHealth Inc.?
The highest price target for GOCO is $25.00 from at , which represents a 346.4% increase from the current price of $5.60.
What is the lowest forecasted price for GOCO GoHealth Inc.?
The lowest price target for GOCO is $18.00 from Ben Hendrix at RBC Capital, which represents a 221.4% increase from the current price of $5.60.
What is the overall GOCO consensus from analysts for GoHealth Inc.?
The overall analyst consensus for GOCO is bullish. Out of 10 Wall Street analysts, 4 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $21.00.
How accurate are GOCO stock price projections?
Stock price projections, including those for GoHealth Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 19, 2025 9:49 PM UTC